ConvEyXO Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

ConvEyXO General Information

Description

Developer of anti-inflammatory and anti-aging therapeutics designed to address unmet medical needs by utilizing extracellular vesicles (EVs). The company focuses on industrializing EV manufacturing using a three-dimensional printed fixed bed, enabling pharmaceuticals as well as biotech firms to produce engineered exosomes, combining cost-effective manufacturing.

Contact Information

Website
conveyxo.com
Formerly Known As
Paracrine Biologicals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • BioPark Charleroi Biotech 4
  • Rue Clément Ader 10
  • 6041 Charleroi
  • Belgium
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • BioPark Charleroi Biotech 4
  • Rue Clément Ader 10
  • 6041 Charleroi
  • Belgium

ConvEyXO Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ConvEyXO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 02-Oct-2025 Completed Generating Revenue
3. Seed Round 01-Aug-2023 Completed Generating Revenue
2. Early Stage VC 29-Jul-2022 $3.06M $5.43M Completed Generating Revenue
1. Early Stage VC 02-Jul-2020 $2.36M $2.36M Completed Generating Revenue
To view ConvEyXO’s complete valuation and funding history, request access »

ConvEyXO Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Class A 32,288 $1.000000 $65.05 $65.05 1x $65.05 12.03%
To view ConvEyXO’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ConvEyXO Patents

ConvEyXO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4759411-A1 Method for loading biological particles with a molecule of interest Pending 16-Dec-2024
WO-2026131650-A1 Method for loading biological particles with a molecule of interest Pending 16-Dec-2024
EP-4656187-A1 Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles Inactive 30-May-2024
WO-2025247999-A1 Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles Pending 30-May-2024
EP-4644537-A1 Targeted extracellular vesicle Inactive 30-Apr-2024 C12N5/0663
To view ConvEyXO’s complete patent history, request access »

ConvEyXO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ConvEyXO Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Saudi Biotechnology Accelerator Accelerator/Incubator
Carbon ( Belgium ) Venture Capital Minority
To view ConvEyXO’s complete investors history, request access »

ConvEyXO FAQs

  • When was ConvEyXO founded?

    ConvEyXO was founded in 2019.

  • Where is ConvEyXO headquartered?

    ConvEyXO is headquartered in Charleroi, Belgium.

  • What is the size of ConvEyXO?

    ConvEyXO has 50 total employees.

  • What industry is ConvEyXO in?

    ConvEyXO’s primary industry is Drug Discovery.

  • Is ConvEyXO a private or public company?

    ConvEyXO is a Private company.

  • What is ConvEyXO’s current revenue?

    The current revenue for ConvEyXO is .

  • How much funding has ConvEyXO raised over time?

    ConvEyXO has raised $6.45M.

  • Who are ConvEyXO’s investors?

    Saudi Biotechnology Accelerator and Carbon ( Belgium ) have invested in ConvEyXO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process